Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine for G-CSF Induced Bone Pain in Multiple Myeloma
NCT04211259Phase 1Recruiting
- Sponsor
- Rutgers University
- Start
- Apr 2022
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in bone pain comparing Cohort I (loratadine) with Cohort II (placebo) (2 cohorts). Primary endpoint: Change in mean pain level. Started Apr 2022; status: recruiting.
02
Drugs
loratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT04211259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04211259.